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Abstract
HSCs are the founder cells of the adult hematopoietic system, and thus knowledge of the
molecular program directing their generation during development is important for regenerative
hematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the
vascular regions of the mouse conceptus - the aorta, vitelline and umbilical arteries, yolk sac and
placenta 1, 2. It is thought that HSCs emerge from vascular endothelial cells through the formation
of intra-arterial clusters 3 and that Runx1 functions during the transition from ‘hemogenic
endothelium’ to HSCs 4, 5. Here we show by conditional deletion that Runx1 activity in vascular
endothelial cadherin (VEC) positive endothelial cells is indeed essential for intra-arterial cluster,
hematopoietic progenitor, and HSC formation. In contrast, Runx1 is not required in cells
expressing Vav, one of the first pan-hematopoietic genes expressed in HSCs. Collectively these
data show that Runx1 function is essential in endothelial cells for hematopoietic progenitor and
HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.
HSCs are found in several independent sites in the conceptus, and the transcription factor
Runx1, which is required for HSC generation, is expressed in these sites 4. Runx1 protein is
seen in the mesodermal masses and endoderm of the prospective yolk sac blood islands at
the neural plate stage 4, 6, in mesoderm of the distal allantois and chorion (precursors of the
placenta) at headfold stages 7, and in endothelial cells in the distal allantois, dorsal aorta,
vitelline and umbilical arteries starting the 4–6 somite pair (s) stage (data not shown). Runx1
is expressed at 9.5–10.5 days post coitus (dpc) in both endothelial and mesenchymal cells in
the dorsal aorta and placental labyrinth 4, 7, 8. Therefore it is not clear whether Runx1 is
required in mesoderm, endoderm, mesenchyme, and/or endothelial cells for intra-arterial
cluster and HSC formation.
To examine the hypothesis that Runx1 is required in endothelial cells per se we deleted
Runx1 in VEC positive cells. VEC is a transmembrane protein located at cell-to-cell
adherens junctions that is involved in endothelial cell adhesion 9. VEC is expressed
transiently in the yolk sac mesoderm at 7.5 dpc, however at 8.5 dpc its expression is highly
restricted to endothelial cells in the dorsal aorta and heart 10–12. At 9.5 dpc VEC is
expressed in vasculature throughout the conceptus 11. Distinct mesodermal populations give
rise to the yolk sac blood islands and to the major arteries of the conceptus, including those
in the placenta 13–15. Thus with VEC-Cre we could monitor the impact of Runx1 excision
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on HSC formation from the vasculature including the dorsal aorta, vitelline and umbilical
arteries, and placenta - sites where VEC expression initiates in endothelium.
We generated a VEC-Cre transgene (Fig. 1a) and used R26R-lacZ and R26R-YFP reporter
mice to characterize its activity. The first sites of VEC-Cre activity were in the yolk sac and
chorionic mesoderm (not shown). Primitive erythrocytes in the yolk sac blood islands were
β-gal+, as were PECAM1+ cells in the vitelline vasculature (Fig. 1b). By 9.5 dpc β-gal
activity was high in vasculature throughout the conceptus (Fig. 1c), particularly within
PECAM1+ cells in the developing labyrinth of the placenta and in the umbilical artery (Fig.
1d). At 10.5 dpc β-gal+ endothelial cells and intra-arterial clusters were present in the dorsal
aorta, vitelline and umbilical arteries, whereas mesenchymal cells were β-gal− (Fig. 1f).
VEC-Cre mediated excision occurred in 77% (± 11%) of cell surface Sca1− VEC+
endothelial cells in the AGM region plus vitelline and umbilical arteries (AGM+V+U) of
11.5 dpc conceptuses and in 86% of Sca1+ VEC+ cells (Fig. 1e) (Sca-1 marks 50% of HSCs,
and VEC marks all HSCs in the AGM region) 2, 16. No excision was detectable in Sca1+
VEC− cells (Fig. 1e). There was widespread VEC-Cre activity in the fetal liver (Fig. 1f,g),
99% of which was localized to CD45+, CD71+, and/or Ter119+ blood cells in R26R-
YFP;VEC-Cre conceptuses (not shown). Approximately 85% of fetal liver blood cells in
15.5 dpc R26R-YFP;VEC-Cre fetuses were YFP+ (Fig, 1h), and are consequently derived
from cells that at one time in their history expressed VEC. Ninety six percent of CD45+
adult bone marrow cells were YFP+ (Fig. 1i), and thus almost all adult blood is derived from
VEC-expressing cells.
VEC-Cre mediated Runx1 deletion caused a 65% rate of fetal lethality (Supplementary
Table 1), and approximately 10% of 12.5 dpc Runx1f/f; VEC-cre fetuses had central nervous
system hemorrhaging and fetal liver anemia characteristic of Runx1 deficiency 17, 18 (Fig.
2a and Supplementary Table 1). There was an 8-fold decrease in c-kit+ cells in the livers of
11.5 dpc Runx1f/f; VEC-cre fetuses (Fig. 2b), and in colony-forming unit culture (CFU-C)
progenitors in all hematopoietic sites (Fig. 2c). DNA analysis revealed that 84% of colonies
derived from Runx1f/+;VEC-Cre fetal cells had excised the Runx1f allele (Fig. 2d and
Supplementary Table 2), consistent with the deletion efficiency determined with the R26R-
YFP allele. In contrast, only one out of 389 colonies picked from cultures established from
Runx1f/f;VEC-cre fetuses had two deleted Runx1f alleles. Thus, at least one functional
Runx1 allele must be present in a VEC+ cell for CFU-C progenitors to emerge in the fetus.
In vivo repopulation assays revealed that hematopoietic tissues of 11.5 dpc Runx1f/f;VEC-
Cre conceptuses could engraft adult mice, but at a much reduced frequency as compared to
Runx1f/+;VEC-cre cells (Fig. 3a,b). While all donor-derived CFU-C progenitors in the
recipients of Runx1f/+;VEC-Cre HSCs had a deleted Runx1f allele, both Runx1f alleles were
deleted in only one out of 192 colonies generated from Runx1f/f;VEC-Cre donor-derived
HSCs (Fig. 3c). We also analyzed the bone marrow of viable Runx1f/f;VEC-Cre adult mice
and found that all colonies retained at least one undeleted Runx1f allele (Supplementary
Table 2). Therefore there is strong selective pressure for cells that escape the excision of at
least one Runx1f allele to contribute to hematopoiesis in Runx1f/f;VEC-Cre mice. Together
these data indicate that Runx1 is required in VEC+ cells for HSC formation.
As the autonomous production of HSCs occurs first in the major arteries of the conceptus at
10.5 dpc (dorsal aorta, vitelline and umbilical) 19, and HSCs localize to the walls of these
arteries 2, 16, we examined intra-arterial cluster formation in Runx1f/f;VEC-Cre embryos.
VEC is expressed on both endothelial cells and intra-arterial clusters, but the first potential
site of deletion is in the endothelium that gives rise to the clusters. No hematopoietic clusters
were visible in the dorsal aorta, vitelline and umbilical arteries of Runx1f/f;VEC-Cre
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animals, and there was a 90-fold decrease in c-kithi cells (Fig. 3d).Thus, the important
deletion event in these arteries occurred in the endothelium.
To confirm this and to determine whether Runx1 continues to be required once the
endothelial to HSC transition is complete, we examined the outcome of deleting Runx1 with
Vav-Cre. Vav1 is a GDP/GTP nucleotide exchange factor for Rho/Rac, whose expression is
restricted to hematopoietic cells 20, 21. Vav1 was also implicated as a Runx1 target, as its
transcript was not detected in the AGM region or fetal liver of Runx1 deficient embryos 22.
Excision of the R26R-YFP allele by Vav-Cre occurred in 68% (±16%) of CD45+VEC−
hematopoietic cells from the AGM region, vitelline and umbilical arteries and not in
CD45−VEC+ endothelium (Fig. 4a). Excised (β-gal+) cells were not found in intra-arterial
clusters at either 10.5 or 11.5 dpc, and were instead located within the sub-aortic
mesenchyme and the circulation (Fig. 4b–d). Therefore Vav-Cre marked cells that either
originated in the yolk sac, or had upregulated Vav-Cre subsequent to their release from the
intra-arterial clusters. β-gal+ cells were detectable in the fetal liver at 10.5 dpc (not shown),
and by 11.5 dpc 63% (±13%) of CD45+VEC− cells in the fetal liver were YFP+ (Fig. 4a)
and were easily seen by histology (Fig. 4e). Fetal liver HSCs transiently express cell surface
VEC 23, 24. Sixty three (±15) percent of the CD45+VEC+ HSC-containing population in the
11.5 dpc fetal liver was YFP+ (Fig. 4a), and by 15.5 dpc 90% of lineage negative Sca1+
Mac1+ fetal liver cells were YFP+ (not shown), similar to the excision frequencies reported
previously 21. Thus with Vav-Cre we could execute an excision in CD45+ cells while
avoiding deletion in the intra-arterial clusters or endothelium.
In contrast to VEC-Cre, excision of Runx1 with Vav-Cre did not affect fetal or adult
viability (Supplementary Table 3). The hematopoietic deficiencies described in adult mice
upon Runx1 deletion with Mx1-Cre, including thrombocytopenia, defective lymphopoiesis,
and expansion of the lineage negative (Lin−) Sca-1+ c-kit+ population 25, 26 were also
apparent in the Vav-Cre deleted mice (Supplementary Figure 2). Fetal livers from 15.5 dpc
Runx1f/f;Vav-Cre mice had increased numbers of CFU-C progenitors, particularly
granulocyte/macrophage (GM) and multipotent (GEMM) progenitors (Fig. 4f), as was
previously observed in the bone marrow of Mx1-Cre deleted adult mice 25, 26. Thus
deletion of Runx1 in Vav+ cells did not impair the emergence of CFU-C progenitors but did
affect their homeostasis. Importantly, both Runx1f alleles were deleted in 280/281 colonies
from 15.5 dpc Runx1f/f;Vav-Cre fetal livers (Supplementary Table 4). Colonies from 11.5
dpc animals contained Runx1f alleles at various stages of deletion (Fig. 4g) since excision is
initiating close to that time. However, 32% of colonies from the hematopoietic tissues of
11.5 dpc fetuses contained two deleted Runx1f alleles, and by 14.5 dpc 100% of fetal liver
progenitors had deleted both alleles (Supplementary Table 4). We therefore conclude that
Runx1 function is no longer required once a CFU-C progenitor expresses Vav.
Mice were efficiently engrafted with hematopoietic tissues from 11.5 dpc Runx1f/f;Vav-Cre
conceptuses (Fig. 4h), and in all colonies (94/94) derived from donor Runx1f/f;Vav-Cre
HSCs, both Runx1f alleles were deleted (Supplementary Table 4). The same was true in
adult Runx1f/f;Vav-Cre mice – virtually all CFU-C progenitors had deleted both Runx1f
alleles (Supplementary Table 4). Hence, Runx1 is not required in a Vav+ HSC.
In summary, the most essential function of Runx1 is during the transition from VEC+ cells
to Vav+ HSCs, although it continues to provide important activity in maintaining normal
HSC function and for the terminal differentiation of some lineages 25, 26 (Supplementary
Figure 1). Our data demonstrate that the relevant VEC+ HSC precursors are in the
hemogenic endothelium. Although the yolk sac mesoderm expresses VEC, in the placenta,
vitelline and umbilical arteries, and dorsal aorta, which are independent hematopoietic sites
derived from distinct populations of mesoderm 13–15, VEC expression is restricted to intra-
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arterial clusters and endothelium. Intra-arterial clusters in these sites are absent in
Runx1f/f;VEC-Cre conceptuses, and therefore the relevant deletion event must have
occurred in the endothelium from which they are derived. Continued deletion by VEC-Cre
in fetal liver HSCs is unlikely because Runx1 is no longer required once HSCs reach the
fetal liver and express Vav, yet they all contain undeleted Runx1f alleles.
We also showed that most adult blood (≥ 95%) is derived from a cell that at one time in its
history expressed VEC. Our working model is that most HSCs are born from VEC+
hemogenic endothelium in the conceptus, although a VEC+ HSC precursor in adult bone
marrow cannot be ruled out. Monvoisin et al. 27 found that a small but detectable number of
bone marrow cells (< 0.4%) could be labeled when a tamoxifen-regulated VEC-Cre was
activated in the adult, hence VEC+ adult HSC precursors, if they exist, are rare cells.
Another model for HSC emergence posits that HSCs in the AGM region originate in
subaortic patches of cells (SAPs) in the ventral para-aortic mesenchyme of the dorsal aorta
28, and migrate toward the aorta and between endothelial cells to form the intra-aortic
clusters. As we showed that almost all blood is derived from VEC+ cells, SAP cells must
upregulate VEC as they protrude through the endothelium.
Methods
Conditional deletion by VEC-Cre or Vav-Cre
A 2.5 kb VEC promoter sequence was cloned between insulators from the chicken γ-globin
gene 29 and used to drive Cre expression. The construct was injected into fertilized oocytes
from C57BL6/J x 129S1/SvImJ F1 mice. R26R-lacZ/+;VEC-Cre or R26R-YFP/+;VEC-Cre
conceptuses were generated by crossing VEC-Cre/+ males with R26R-lacZ/+ or R26R-YFP/
+ females. Runx1f/+;VEC-Cre and Runx1f/f;VEC-Cre conceptuses were generated by
crossing Runx1f/+; VEC-Cre/+ males with Runx1f/f females. Runx1f/+;R26R-YFP/+;VEC-
Cre or Runx1f/f;R26R-YFP/+;VEC-Cre conceptuses were generated from crossing
Runx1f/+;R26R-YFP/+; VEC-Cre/+ males with Runx1f/f females. Similar breeding
strategies were employed for Vav-Cre deletion.
Microscopic and histological analyses
Conceptuses were suspended in phosphate-buffered saline or in a 1:2 mixture of benzyl
alcohol/benzyl benzoate and visualized with a stereomicroscope. X-gal (Sigma) staining was
performed as described previously 4. In some cases the conceptuses were also incubated
with rat anti-mouse Pecam1 and ABC reagent at 4°C 30, then treated with DAB peroxidase
substrate. Conceptuses were embedded in paraffin, sectioned, and counterstained with
nuclear fast red.
To analyze intra-aortic clusters, embryos were fixed and stained with anti-c-Kit and anti-
PECAM1-antibodies. A 1:2 mix of benzyl alcohol/benzyl benzoate was used to increase the
transparency of tissues. Samples were analyzed with a confocal microscope using the multi
track sequential mode. Three-dimensional reconstructions were generated from Z-stacks
(62–87 serial sections).
Hematopoietic assays
Methylcellulose colony forming assays were performed as described previously 4 and
colonies counted after 7 days. Fetal tissues were transplanted as previously described 16.
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Immuno-staining was performed with phycoerytherin, allophycocyanin, or Alexa Fluor 647
conjugated antibodies Stained cells were analyzed on a Becton Dickinson FACSCalibur
flow cytometer. Dead cells were excluded with 7AAD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. VEC-Cre excision marks endothelium and blood
a. Schematic diagram of the VEC-Cre transgene. The VEC promoter (VEC-pro) and Cre
plus polyA tail (Cre-pA) were flanked by insulator sequences from the chicken γ-globin
gene.
b. Sagittal section of a 5 s R26R-lacZ;VEC-Cre conceptus near the hindgut(hg). Arrows
indicate β-gal+ (blue) PECAM1+ (brown) vitelline vasculature. ys, yolk sac; bi, blood
island. The blood island contains β-gal+ primitive erythrocytes derived from yolk sac
mesoderm in which VEC-Cre was active.
c. Whole mount conceptuses showing β-gal activity in the embryonic vasculature and
placenta (pl).
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d. VEC-Cre excision in placenta and umbilical artery endothelium. Left panel is from a 9.5
dpc conceptus. Detail of boxed region in placental labyrinth is to the right. β-gal+ cells are
blue and PECAM1+ cells are brown. On the far right is a transverse section through a 10.0
dpc R26R-lacZ;VEC-Cre conceptus with abundant β-gal+ endothelial cells in the placenta
(pl) and umbilical artery (u). da, dorsal aorta; ys, yolk sac.
e. FACS analysis of cells from the AGM region, vitelline and umbilical arteries of 11.5 dpc
R26R-YFP;VEC-Cre conceptuses stained for Sca1, VEC, Ter119, and 7-AAD. Gated
populations in scatter plot were analyzed for YFP in histograms to the right. Graph shows
percent of YFP+ cells in each subpopulation, line indicates mean. Non-hematopoietic, non-
endothelial cells (Sca1+ VEC−) are YFP−. Means (± SD) for each population are: Sca1+
VEC− (0.7 ± 0.2); Sca1+ VEC+ (86.4 ± 9.9); Sca1−VEC+ (77.4 ± 11.1).
f. On left is a transverse section through the AGM region of a 10.5 dpc conceptus. Detail on
right is from boxed region showing β-gal+ endothelial cells (e) and hematopoietic clusters
(hc) in the dorsal aorta (da). Note that the sub-aortic mesenchyme (m) is β-gal−. fl, fetal
liver.
g. β-gal+ cells in the liver of R26R-lacZ;VEC-Cre fetuses (10.5 dpc).
h. Percentage of YFP+ fetal liver cells of multiple cell surface phenotypes (gated from
Ter119− 7-AAD− cells) from 15.5 dpc R26R-YFP;VEC-Cre conceptuses. Mean ± SD for
each population: CD45hi (85.6 ± 6.3); CD45− VEC+ (85.7 ± 8.2); CD31hi VEC+ (94.2 ±
2.8); CD34+ c-kit+ (86.1 ± 6.4); Sca1+ Mac1+ (89.9 ± 5.1); Gr1+ (73.6 ± 10.3); Mac1+ (82.3
± 7.6); B220+ (82.4 ± 7.9); CD3/4/8+ (89.4 ± 6.4).
i. Percentage of YFP+ bone marrow cells (gated from Ter119− 7-AAD− cells) in R26R-
YFP;VEC-Cre adult mice. CD45hi (96.1 ± 3.3); LSK (95.5 ± 4.4); CD34+ c-kit+ (95.2 ±
4.9); CD41+ (95.1 ± 4.9); CD31+ (95.4 ± 3.5); Gr1+ (95.0 ± 3.2); Mac1+ (96.5 ± 3.6); B220+
(96.0 ± 4.2); CD3/4/8+ (88.4 ± 4.1).
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Figure 2. Runx1 is required in VEC+ cells for hematopoietic progenitor formation
a. Gross appearance of Runx1f/f;VEC-Cre fetuses. Note the central nervous system
hemorrhaging (white asterisks) and pale fetal liver (fl). VEC-Cre deletion of Runx1 resulted
in the same phenotype as germline Runx1 deletion, but the penetrance was lower.
b. FACS analysis of Ter119− 7-AAD− cells from 11.5 dpc fetal livers. Error bars in plot on
right represent 95% confidence intervals. Significant differences from combined +/+, f/+,
and f/f samples are indicated with asterisks (*P = 0.05, **P = 0.01; ANOVA and Dunnett’s
multiple comparison test).
d. CFU-C assays of yolk sac, combined AGM region, umbilical and vitelline arteries (AGM
+U+V), placenta, and fetal liver (represented as numbers per embryo equivalent, error bars
indicate 95% confidence intervals). Significant differences from Runx1f/f or Runx1f/+
conceptuses are indicated with asterisks (**P = 0.01). Data are averaged from 16 litters, with
10 – 31 animals per genotype.
d. PCR genotyping of single colonies picked from CFU-C assays. On top is shown locations
of the three primers (colored triangles) used to detect the wildtype (+), floxed (f), and
deleted (Δ) Runx1 alleles. LoxP sites are open triangles. The combined number of colonies
from 11.5 dpc AGM+V+U and fetal livers of each genotype are indicated below the gel.
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Since Runx1 haploinsufficiency decreases the number of CFU-Cs 18, the percentage of
Runx1f/Δ colonies may actually underestimate the excision frequency.
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Figure 3. Runx1 is required in VEC+ cells for HSC emergence
a. Scheme of transplantations and analyses. Donor derived cells were isolated from
transplant recipients and plated in methylcellulose assays, and individual colonies were
genotyped.
b. Engraftment as assessed by FACS on peripheral blood to detect donor derived (Ly5.1−/
5.2+) cells. Numbers indicate successfully reconstituted recipients (>5% donor-derived
cells) per number transplanted. Mice were transplanted with one embryo equivalent of 11.5
dpc fetal cells from each site. Control samples are from Runx1f/f, Runx1f/+ and
Runx1f/+;VEC-Cre conceptuses.
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c. PCR genotyping of single colonies picked from CFU-C assays of donor-derived placenta
cells sorted from the bone marrow of transplant recipients. The number of colonies of each
genotype is indicated below the gel.
d. Confocal images of the caudal region of 10.5 dpc embryos (35–36 s) stained with
antibodies to PECAM1 (pink) and c-kit (green). Diagram on left illustrates area analyzed
(da, dorsal aorta; v, vitelline artery; u, umbilical artery). Arrow indicates a c-kit+ cluster in
the ventral aspect of the dorsal aorta. On right is a bar graph representing the number of c-
kit+ cells in the dorsal aorta from three embryos of each genotype. Error bars represent
standard deviation.
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Figure 4. Runx1 is not required in Vav+ cells for CFU-C or HSC emergence
a. Flow cytometric assay of AGM region, vitelline and umbilical arteries (AGM+V+U) and
fetal livers from 11.5 dpc R26R-YFP;Vav-Cre conceptuses demonstrating deletion in blood
but not in endothelium. Scatter plot shows 7AAD− Ter119− cells gated and analyzed for
CD45 and VEC expression. Histograms to the right represent the percent of YFP positive
cells (± SEM) in each of the gated populations. The CD45+VEC+ population from the AGM
+V+U was too small to analyze for YFP expression. Graph on far right in top row shows
mean ± SEM for AGM+V+U. Activation of the R26R-YFP allele in both fetal liver
endothelium (CD45− VEC+) and blood (CD45+ VEC− and CD45+ VEC+) with VEC-Cre is
shown at the bottom for comparison.
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b. Dorsal aorta from the AGM region of a 10.5 dpc R26R-lacZ;Vav-Cre conceptus. Arrow
points to an intra-aortic cluster, all of which are β-gal−.
c. Transverse section through the dorsal aorta of an 11.5 dpc R26R-lacZ;Vav-Cre conceptus.
Arrows indicate two β-gal+ cells in the subaortic mesenchyme.
d. Detail of β-gal+ cell in the subaortic mesenchyme from boxed region in c.
e. β-gal+ cells in the fetal liver (11.5 dpc).
f. CFU-C assays from 15.5 dpc fetal livers. Asterisks indicate significant differences from f/
+ or f/f animals (P = 0.05, ANOVA and Dunnett’s multiple comparison test). Data are
compiled from 3–8 conceptuses of each genotype. Error bars represent 95% confidence
intervals.
g. PCR genotyping of colonies from CFU-C assays. The gel is from 11.5 dpc AGM+V+U
colonies. Horizontal lines above lanes are Runx1f/f;Vav-Cre colonies, and Runx1f/+;Vav-Cre
colonies are labeled f/+. Asterisks indicate colonies in which both Runx1f alleles (or in the
case of Runx1f/+;Vav-Cre colonies, one Runx1f allele) were completely deleted. Numbers
below the gel represent total colonies from 11.5 dpc tissues (AGM+V+U, yolk sac, placenta,
fetal liver).
h. Engraftment of 11.5 dpc tissues (1 ee) as assessed by FACS on peripheral blood to detect
donor derived (Ly5.1−/5.2+) cells. Numbers within bars indicate successfully reconstituted
recipients/number transplanted.
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